Indigo Life Sciences Ltd 12481219 false 2023-03-01 2024-02-29 2024-02-29 The principal activity of the company is employment placement agencies. Digita Accounts Production Advanced 6.30.9574.0 true 12481219 2023-03-01 2024-02-29 12481219 2024-02-29 12481219 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 12481219 bus:Micro-entities 2023-03-01 2024-02-29 12481219 bus:Audited 2023-03-01 2024-02-29 12481219 bus:FullAccounts 2023-03-01 2024-02-29 12481219 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 12481219 bus:RegisteredOffice 2023-03-01 2024-02-29 12481219 bus:Director1 2023-03-01 2024-02-29 12481219 bus:Director2 2023-03-01 2024-02-29 12481219 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 12481219 bus:Agent1 2023-03-01 2024-02-29 12481219 countries:AllCountries 2023-03-01 2024-02-29 12481219 2022-03-01 2023-02-28 12481219 2023-02-28 12481219 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 iso4217:GBP xbrli:pure

Registration number: 12481219

Indigo Life Sciences Ltd

Annual Report and Financial Statements

for the Year Ended 29 February 2024

 

Indigo Life Sciences Ltd

Contents

Company Information

1

Accountants' Report

2

Balance Sheet

3 to 4

Notes to the Financial Statements

3

 

Indigo Life Sciences Ltd

Company Information

Directors

Mr E Pooley

Mr C M Phethean

Registered office

Optima House
1 Mill Court
Spindle Way
Crawley
West Sussex
RH10 1TT

Accountants

Andrews & O'Shea Ltd
Optima House
1 Mill Court
Spindle Way
Crawley
West Sussex
RH10 1TT

 

Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Indigo Life Sciences Ltd
for the Year Ended 29 February 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Indigo Life Sciences Ltd for the year ended 29 February 2024 as set out on pages 3 to 4 from the company's accounting records and from information and explanations you have given us.

This report is made solely to the Board of Directors of Indigo Life Sciences Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Indigo Life Sciences Ltd and state those matters that we have agreed to state to the Board of Directors of Indigo Life Sciences Ltd, as a body, in this report and for no other reason. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Indigo Life Sciences Ltd and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Indigo Life Sciences Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Indigo Life Sciences Ltd. You consider that Indigo Life Sciences Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Indigo Life Sciences Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

Andrews & O'Shea Ltd
Optima House
1 Mill Court
Spindle Way
Crawley
West Sussex
RH10 1TT

26 October 2024

 

Indigo Life Sciences Ltd

(Registration number: 12481219)
Balance Sheet as at 29 February 2024

2024
£

2023
£

Fixed assets

3,260

7,655

Current assets

28,962

89,676

Creditors: Amounts falling due within one year

(8,814)

(14,494)

Net current assets

20,148

75,182

Total assets less current liabilities

23,408

82,837

Accruals and deferred income

(1,800)

(1,185)

 

21,608

81,652

Capital and reserves

21,608

81,652

1

General information

The company is a private company limited by share capital, incorporated in England and Wales..

The address of its registered office is:
Optima House
1 Mill Court
Spindle Way
Crawley
West Sussex
RH10 1TT

These financial statements were authorised for issue by the Board on 26 October 2024.

Basis of preparation

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 4 (2023 - 4).

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the Board on 26 October 2024 and signed on its behalf by:
 

 

Indigo Life Sciences Ltd

(Registration number: 12481219)
Balance Sheet as at 29 February 2024

.........................................
Mr E Pooley
Director

.........................................
Mr C M Phethean
Director